ReviewBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz2025
[Vaccination reminders in Germany: inventory and ideas for tomorrow using the example of HPV vaccination : Report on the results of the InveSt HPV project].
Review in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Awareness of human papillomavirus (HPV) vaccination for girls and boys in Germany-results of the LIEBESLEBEN study].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In Germany, vaccinations take place almost exclusively in physicians' private practices. This means that every contact with a practice or physician is an important opportunity to receive a recommended vaccination. The effectiveness of invitation and reminder systems for the implementation of recommended vaccinations has already been proven by studies, but in contrast to many other countries, such systems are not used across the board in Germany. The "Intervention Study to Increase HPV Vaccination Coverage in Germany" (InveSt HPV) therefore addresses, among other things, the question of what barriers exist to the use and dissemination of invitation and vaccination reminder systems. To this end, two nationwide quantitative surveys of (i) 345 pediatricians in private practices and (ii) 1805 parents with children aged 9 to 14 as well as a survey of 46 statutory health insurances with around 51 million insured persons were conducted. The survey results and other evidence compiled by the project team formed the basis for a workshop with vaccination-relevant stakeholders from the healthcare sector. The aim of the workshop was to work together on concepts for a future invitation and vaccination reminder system in Germany using the specific example of the HPV (Human Papillomavirus) vaccination. This report presents the core results of the surveys conducted and selected additional evidence compiled by the project team for the workshop. Finally, the workshop and the key elements developed by the participants for an HPV-related invitation and vaccination reminder system 2.0 are described.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.